TWI372048B - Anti-coronavirus compounds - Google Patents
Anti-coronavirus compoundsInfo
- Publication number
- TWI372048B TWI372048B TW094114468A TW94114468A TWI372048B TW I372048 B TWI372048 B TW I372048B TW 094114468 A TW094114468 A TW 094114468A TW 94114468 A TW94114468 A TW 94114468A TW I372048 B TWI372048 B TW I372048B
- Authority
- TW
- Taiwan
- Prior art keywords
- coronavirus
- compounds
- coronavirus compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56808004P | 2004-05-04 | 2004-05-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200600084A TW200600084A (en) | 2006-01-01 |
TWI372048B true TWI372048B (en) | 2012-09-11 |
Family
ID=36647910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094114468A TWI372048B (en) | 2004-05-04 | 2005-05-04 | Anti-coronavirus compounds |
Country Status (7)
Country | Link |
---|---|
US (1) | US8481571B2 (zh) |
JP (1) | JP2007536240A (zh) |
CN (1) | CN1949977B (zh) |
AU (1) | AU2005323435A1 (zh) |
NZ (1) | NZ550945A (zh) |
TW (1) | TWI372048B (zh) |
WO (1) | WO2006073456A2 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2782922T (pt) * | 2011-11-25 | 2018-02-05 | The Kitasato Inst | Derivados antibacterianos de tilosina e processos para a sua preparação |
WO2013184780A1 (en) * | 2012-06-06 | 2013-12-12 | Unither Virology, Llc | Novel iminosugars and their applications |
US11285142B2 (en) | 2015-09-29 | 2022-03-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions and methods for identifying and treating dystonia disorders |
WO2017201052A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating zika virus infection |
CN107595906B (zh) * | 2017-11-10 | 2020-10-30 | 中国药科大学 | 常春藤皂苷元及其糖苷在制备抗病毒的药物中的应用 |
MX2021014742A (es) * | 2019-06-05 | 2022-02-11 | Univ Emory | Peptidomimeticos para el tratamiento de infecciones por coronavirus y picornavirus. |
US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
JPH0778021B2 (ja) * | 1988-04-13 | 1995-08-23 | 太陽化学株式会社 | 下痢症ウイルス感染阻害剤 |
US5156973A (en) * | 1988-11-23 | 1992-10-20 | Edward Shanbrom | Antiviral blood sampling process and apparatus |
HUT64738A (en) * | 1990-06-01 | 1994-02-28 | Du Pont Merck Pharma | Process for preparing 1,4-diamino-2,3-dihydroxi-butane compounds and pharmaceutical compositions contianing them |
JPH04297475A (ja) * | 1991-03-26 | 1992-10-21 | Yamanouchi Pharmaceut Co Ltd | 抗ウイルス剤 |
US6803466B1 (en) | 1997-12-08 | 2004-10-12 | The Scripps Research Institute | HIV/FIV protease inhibitors having a small P3 residue |
-
2005
- 2005-05-03 WO PCT/US2005/015227 patent/WO2006073456A2/en active Application Filing
- 2005-05-03 JP JP2007511484A patent/JP2007536240A/ja active Pending
- 2005-05-03 AU AU2005323435A patent/AU2005323435A1/en not_active Abandoned
- 2005-05-03 NZ NZ550945A patent/NZ550945A/en not_active IP Right Cessation
- 2005-05-03 CN CN2005800143095A patent/CN1949977B/zh not_active Expired - Fee Related
- 2005-05-03 US US11/121,314 patent/US8481571B2/en not_active Expired - Fee Related
- 2005-05-04 TW TW094114468A patent/TWI372048B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US8481571B2 (en) | 2013-07-09 |
AU2005323435A1 (en) | 2006-07-13 |
TW200600084A (en) | 2006-01-01 |
WO2006073456A3 (en) | 2006-09-14 |
WO2006073456A2 (en) | 2006-07-13 |
CN1949977B (zh) | 2010-09-29 |
JP2007536240A (ja) | 2007-12-13 |
CN1949977A (zh) | 2007-04-18 |
NZ550945A (en) | 2010-04-30 |
US20060160866A1 (en) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0405933D0 (en) | Compounds | |
IL178330A0 (en) | Neurologically-active compounds | |
GB0405937D0 (en) | Compounds | |
TWI372048B (en) | Anti-coronavirus compounds | |
EP1755617A4 (en) | PERFLUORCARBON-SOLUBLE COMPOUNDS | |
GB0405193D0 (en) | Compounds | |
GB0405272D0 (en) | Compounds | |
GB0405267D0 (en) | Compounds | |
GB0401269D0 (en) | Compounds | |
GB0408772D0 (en) | Compounds | |
GB0405280D0 (en) | Compounds | |
GB0405893D0 (en) | Compounds | |
GB0403593D0 (en) | Compounds | |
GB0406916D0 (en) | Compounds | |
GB0403595D0 (en) | Compounds | |
GB0406963D0 (en) | Compounds | |
GB0405774D0 (en) | Compounds | |
GB0403998D0 (en) | Compounds | |
GB0403267D0 (en) | Compounds | |
GB0403334D0 (en) | Compounds | |
GB0403993D0 (en) | Compounds | |
GB0400695D0 (en) | Compounds | |
GB0406918D0 (en) | Compounds | |
GB0404081D0 (en) | Compounds | |
GB0400696D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |